Sustainability of Treatment Success 5 Years after Exposure-Based Cognitive-Behavioral Therapy for Anxiety Disorders
In brief
Exposure-based CBT gains largely held for five years in anxiety patients
Among 355 patients followed, improvements in anxiety symptoms and daily functioning after exposure-based cognitive behavioral therapy were largely maintained at five years; 4.9% had a reliable relapse, while 63.4% sought no additional treatment. Follow-up included 58% of eligible patients, and additional treatment was linked to greater symptom severity, leaving open how best to help those who do not recover or relapse.
- Journal
- Psychotherapy and psychosomatics (Q1)
- Published
- 16 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Andre Pittig, Ingmar Heinig, Volker Arolt, Christina Bartnick, Udo Dannlowski, Jürgen Deckert, et al.
- PMID
- 43038312
- DOI
- 10.1159/000549073
Why clinicians should know about it
- Picked for Psychiatry and Mental Health (paper of the day, 17 November 2026): Long-term outcomes after exposure-based CBT for anxiety disorders
Abstract
INTRODUCTION: Achieving sustainable success in the treatment of anxiety disorders remains a central objective in mental health care. Although research has demonstrated the short-term efficacy of psychotherapy, evidence regarding long-term sustainability is limited. This study examined treatment outcomes 5 years after prediction-error-based exposure therapy. METHODS: For 355 patients (616 eligible; 58% follow-up rate), newly collected follow-up data on anxiety symptoms and psychosocial functioning were compared to pretreatment, posttreatment, and 6-month follow-up data from a multicenter clinical trial characterized by high treatment fidelity. RESULTS: Improvements in anxiety symptoms and psychosocial functioning that were evident at posttreatment and 6-month follow-up were largely preserved after 5 years. No significant differences emerged between randomized groups of temporally intensified and non-intensified exposure. From 6 months to 5 years, overall remission rates remained stable, with the majority of patients exhibiting no reliable change in symptom severity. Reliable relapse occurred in 4.9% and reliable new remission in 6.5%. Most patients (63.4%) did not seek additional treatment. Among those who did, depression (64.2%) and anxiety (60.5%) were the most frequently cited reasons, although only a minority (6.0%) sought further treatment exclusively for anxiety. Additional treatment during the follow-up period was associated with higher symptom severity throughout assessments. CONCLUSION: These findings highlight the sustainability and long-term public health benefits of exposure-based CBT for anxiety disorders. Most patients do not need additional treatments for mental disorders even 5 years after treatment. Nevertheless, further efforts are needed to optimize interventions for those patients who do not achieve remission or experience relapse.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.